fda import alert green list glp-1 semaglutide tirzepatide 2025 unveils new safeguard in battle over popular weight-loss drugs September 8, 2025: FDA launches

[20] Is long-term use considered safe

And while its important to be aware of possible side effects, severe gastrointestinal conditions like gastroparesis have not been linked to this medication

Interestingly, both US and U.K

One of the biggest studies to draw attention looked at adults with overweight or obesity and established cardiovascular disease, but without diabetes

Hence, despite some preliminary evidence is available supporting the use of antimicrobials in the clinical management of BD, further studies are warranted to evaluate the effects of antimicrobials in the gut microbiota and its association with clinical outcomes in these patients